Skip to main content

Military Health System

Clear Your Browser Cache

This website has recently undergone changes. Users finding unexpected concerns may care to clear their browser's cache to ensure a seamless experience.

Innovative mobile technologies impact DOD health surveillance

Image of Medical personnel using a syringe to inject a fluid into a test tube. Dr. Peter Larson loads an Oxford Nanopore MinION sequencer in support of COVID-19 sequencing assay development at the U.S. Army Medical Research Institute of Infectious Diseases, Fort Detrick, Maryland. (Photo by John Braun Jr., USAMRIID.)

The COVID-19 pandemic has highlighted the importance of collaboration and information-sharing forums for those working in the health field.

An example of one such forum is the Armed Forces Health Surveillance Division (AFHSD), Global Emerging Infections Surveillance (GEIS) Branch’s Next Generation Sequencing and Bioinformatics Consortium (NGSBC) and their mobile next generation sequencing (NGS) working group.

The NGSBC was created in 2017, bringing together DOD partners for coordination and improvement of pathogen genetic sequencing and analysis efforts. Subject matter experts from the Naval Medical Research Center, U.S. Army Medical Research Institute of Infectious Diseases (USAMRIID), Walter Reed Army Institute of Research, U.S. Air Force School of Aerospace Medicine, and the Naval Health Research Center assist the overseas service laboratories and other partners with protocol development, sample processing, and sequence data analysis.

As genetic sequencing capabilities have evolved and grown, so has the desire to have mobile platforms that could shorten the time from sample collection to final results reporting. Therefore GEIS and partners are exploring the use of mobile NGS technology in the laboratory, the field, and austere environments. To support these efforts, the mobile NGS working group was derived from the NGSBC in 2019 and focuses on increasing knowledge and use of mobile NGS technologies.

“This is a much needed working group to connect portable sequencing platform users across the DOD,” said Dr. Cory Bernhards, a member of the group who uses mobile NGS methods. “It will boost efficiency and foster collaboration among the different laboratories.”

The mobile NGS forum supports communication and collaboration between DOD and other government laboratories by creating a platform for partners to share protocols and provide training sessions. Participants meet regularly to discuss issues like how to address unique matters related to the way work is conducted in the field and not in a traditional lab - such as how to keep reagents and supplies at safe temperatures and how to perform remote complex computer-based data analysis. They also present use cases of pathogenic viruses including SARS-CoV-2 sequencing results from the Oxford Nanopore MinION, a type of mobile NGS technology.

“This working group will greatly accelerate progress toward fielding sequencing capabilities to serve and protect the warfighter,” said Bernhards.

The working group currently has more than 100 participants from 28 different organizations, including interagency partners from Centers for Disease Control and Prevention and Food and Drug Administration.

GEIS will continue to support partners in implementing capabilities for mobile NGS platforms, to set goals for using the technology, and to provide resources to address challenges. Navy Capt. Guillermo Pimentel, chief of GEIS, expressed his optimism for this mobile lab capability. 

"Having a mobile sequencing capability could provide an advantage in the early detection of an infectious disease that could negatively impact our deployed forces." Pimentel also highlighted the potential use of the technology, “The platform could also be used to determine if insects collected as part of regular vector surveillance carry viruses that could cause diseases in an operational setting."

You also may be interested in...

Publication
May 26, 2020

Force Health Protection Guidance (Supplement 9) -Department of Defense Guidance for Deployment and Redeployment of Individuals and Units during the Novel Coronavirus Disease 2019 Pandemic

.PDF | 243.02 KB

This memorandum provides force health protection (FHP) deployment and redeployment guidance for Service members (including Reserve Component (RC) and National Guard members in a title 10 or title 32 duty status) and DoD civilian employees deploying within and outside the United States during the COVID-19 pandemic, consistent with references (a) and (b).

Publication
Apr 20, 2020

Modification and Reissuance of DoD Response to Coronavirus Disease 2019 -Travel Restrictions

.PDF | 960.08 KB

All DoD Service members will stop movement, both internationally and domestically, while this memorandum is in effect. All DoD civilian personnel, and dependents of DoD Service members and DoD civilian personnel, whose travel is Government-funded will stop movement, both internationally and domestically, while this memorandum is in effect.

Publication
Apr 7, 2020

Decision Memorandum on TRICARE Implementation of the "Families First Coronavirus Response Act"

.PDF | 1.06 MB

The Families First Coronavirus Response Act, Public Law 116-127, Division F, Section 6006(a), limits TRICARE authority to impose copayment or other cost-sharing for novel coronavirus (COVID-19) testing and related provider visits that result in orders for or administration of Food and Drug Administration (FDA) approved, cleared, or authorized ...

Publication
Apr 5, 2020

DoD Guidance on the Use of Cloth Face Coverings

.PDF | 1.02 MB

Effective immediately, to the extent practical, all individuals on DoD property, installations, and facilities will wear cloth face coverings when they cannot maintain six feet of social distance in public areas or work centers (this does not include in a Service member's or Service family member's personal residence on a military installation).

Publication
Apr 2, 2020

Transition of Military Medical Treatment Facilities from Military Departments to the Defense Health Agency during the COVID-19 Response

.PDF | 457.94 KB

The Department's MTF transition plan is conditions-based. While the transition of MTFs to DHA is continuing, the COVID-19 response requirements are impacting DHA's ability to meet all required conditions. The need for the DHA and MILDEPs to refocus efforts away from the transition to support the COVID-19 response led to questions regarding the future ...

Refine your search
Last Updated: July 11, 2023
Follow us on Instagram Follow us on LinkedIn Follow us on Facebook Follow us on Twitter Follow us on YouTube Sign up on GovDelivery